Tomasz Beer, M.D.

Dr. Tomasz (Tom) Beer serves as Vice President & Chief Medical Officer for Multi-Cancer Early Detection (MCED) at Exact Sciences Corporation. He oversees the clinical development of the company’s MCED test, to expand screening beyond the handful of cancers screened for today.

Prior to Exact Sciences, Dr. Beer was Chief Medical Officer and Deputy Cancer Center Director for the Center for Early Detection Advanced Research (CEDAR) where he led collaborations among clinicians, engineers, and cancer biologists and directed clinical trials of multi-omic blood-based cancer early detection tests.

Dr. Beer has authored or co-authored more than 290 peer reviewed articles on multi-cancer early detection, cancer survivorship, and emerging therapies. His work definitively showed overall survival gains with enzalutamide therapy, establishing a new standard of care for advanced prostate cancer.

Dr. Beer also maintains an adjunct faculty appointment at the Oregon Health & Science University (OHSU) Knight Cancer Institute, where he sees men with prostate cancer and serves on the American Cancer Society’s Discovery Council.